The R&D contracts for the discovery and validation of proteomic biomarkers can include phases of experimental design and sample preparation; analysis of differential expression of proteins by absolute quantification (stable isotypes) or relative (spectral counts) of proteins contained in complex matrix or biological fluids; bioinformatics analysis of proteomic data and validation of targets by advanced mass spectrometry